Skip to main content
James Griffin, MD, Oncology, Boston, MA

JamesDouglasGriffinMD

Oncology Boston, MA

Hematologic Oncology

Oncologist at Dana Farber

Dr. Griffin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Griffin's full profile

Already have an account?

  • Office

    450 Brookline Avenue
    Dana-Farber Cancer Institute
    Boston, MA 02215
    Phone+1 617-632-3360
    Fax+1 617-632-2260

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1979 - 1980
  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1976 - 1977
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1974 - 1976
  • Harvard Medical School
    Harvard Medical SchoolClass of 1974

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1975 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1989
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • 'World First' For Double Hand Transplant Patient
    'World First' For Double Hand Transplant PatientMay 10th, 2024
  • RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory Board
    RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory BoardApril 25th, 2017
  • TFS Appoints Dr. Bassem Saleh as Chief Medical Officer and Mr. Edward (Ed) Tumaian as VP Global Clinical Development
    TFS Appoints Dr. Bassem Saleh as Chief Medical Officer and Mr. Edward (Ed) Tumaian as VP Global Clinical DevelopmentMarch 22nd, 2017
  • Join now to see all

Professional Memberships